Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Diaphragm | 5 | 2019 | 232 | 2.33 | Why? |
| Ventilator Weaning | 5 | 2018 | 536 | 1.68 | Why? |
| Oxygen Inhalation Therapy | 8 | 2019 | 3629 | 1.39 | Why? |
| Respiratory Insufficiency | 15 | 2021 | 7301 | 1.22 | Why? |
| Pleural Effusion | 2 | 2018 | 680 | 0.89 | Why? |
| Brain Neoplasms | 2 | 2018 | 669 | 0.87 | Why? |
| Interactive Ventilatory Support | 2 | 2017 | 25 | 0.83 | Why? |
| Dyspnea | 6 | 2019 | 3847 | 0.83 | Why? |
| Intensive Care Units | 27 | 2021 | 29594 | 0.74 | Why? |
| Ear Protective Devices | 1 | 2017 | 11 | 0.73 | Why? |
| High-Frequency Ventilation | 1 | 2018 | 57 | 0.73 | Why? |
| Pneumonia, Aspiration | 1 | 2018 | 69 | 0.71 | Why? |
| Immunocompromised Host | 6 | 2019 | 5150 | 0.68 | Why? |
| Respiration, Artificial | 13 | 2019 | 22116 | 0.64 | Why? |
| Sleep Deprivation | 1 | 2017 | 175 | 0.62 | Why? |
| Eye Protective Devices | 1 | 2017 | 245 | 0.56 | Why? |
| Pneumonia, Pneumocystis | 1 | 2018 | 322 | 0.54 | Why? |
| Positive-Pressure Respiration | 2 | 2020 | 1160 | 0.50 | Why? |
| Critical Illness | 8 | 2020 | 17281 | 0.45 | Why? |
| Extracorporeal Membrane Oxygenation | 6 | 2020 | 5002 | 0.44 | Why? |
| Intubation, Intratracheal | 6 | 2020 | 3962 | 0.41 | Why? |
| Noninvasive Ventilation | 7 | 2019 | 2329 | 0.40 | Why? |
| Critical Care | 7 | 2021 | 14081 | 0.38 | Why? |
| Oxygen | 2 | 2019 | 3715 | 0.34 | Why? |
| Correspondence as Topic | 2 | 2017 | 50 | 0.33 | Why? |
| France | 11 | 2021 | 12074 | 0.30 | Why? |
| Sepsis | 2 | 2018 | 3517 | 0.27 | Why? |
| Bereavement | 2 | 2017 | 296 | 0.23 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.22 | Why? |
| Pectoralis Muscles | 1 | 2019 | 21 | 0.21 | Why? |
| Paris | 3 | 2021 | 1287 | 0.20 | Why? |
| Stress Disorders, Traumatic | 1 | 2020 | 78 | 0.20 | Why? |
| Catastrophic Illness | 1 | 2019 | 41 | 0.20 | Why? |
| Myosin Heavy Chains | 1 | 2018 | 26 | 0.19 | Why? |
| Injections, Intraperitoneal | 1 | 2018 | 69 | 0.19 | Why? |
| Atrophy | 1 | 2019 | 192 | 0.19 | Why? |
| Terminally Ill | 1 | 2018 | 40 | 0.19 | Why? |
| Membranes, Artificial | 1 | 2020 | 175 | 0.18 | Why? |
| Sodium Bicarbonate | 1 | 2018 | 54 | 0.18 | Why? |
| Karnofsky Performance Status | 1 | 2017 | 88 | 0.18 | Why? |
| Ultrasonography | 3 | 2020 | 4409 | 0.17 | Why? |
| Equivalence Trials as Topic | 1 | 2018 | 242 | 0.17 | Why? |
| Phrenic Nerve | 1 | 2017 | 37 | 0.17 | Why? |
| Magnetic Fields | 1 | 2017 | 26 | 0.17 | Why? |
| Protein Isoforms | 1 | 2018 | 347 | 0.17 | Why? |
| Acute Disease | 6 | 2020 | 6029 | 0.17 | Why? |
| Acidosis | 1 | 2018 | 125 | 0.17 | Why? |
| Muscle Contraction | 1 | 2017 | 60 | 0.17 | Why? |
| Glasgow Coma Scale | 1 | 2017 | 249 | 0.16 | Why? |
| Humans | 49 | 2021 | 930598 | 0.16 | Why? |
| Hospitals, Low-Volume | 1 | 2018 | 355 | 0.16 | Why? |
| Prognosis | 7 | 2019 | 32490 | 0.16 | Why? |
| Endotoxemia | 1 | 2018 | 143 | 0.16 | Why? |
| Organ Dysfunction Scores | 2 | 2020 | 1475 | 0.16 | Why? |
| Rats, Wistar | 1 | 2018 | 621 | 0.16 | Why? |
| Cannula | 2 | 2021 | 750 | 0.16 | Why? |
| Polysomnography | 1 | 2017 | 296 | 0.15 | Why? |
| Muscle Weakness | 1 | 2019 | 406 | 0.15 | Why? |
| Capillary Leak Syndrome | 1 | 2017 | 119 | 0.15 | Why? |
| Ventilators, Mechanical | 2 | 2019 | 2193 | 0.15 | Why? |
| Professional-Family Relations | 2 | 2017 | 424 | 0.15 | Why? |
| Middle Aged | 24 | 2021 | 270681 | 0.15 | Why? |
| Noise | 1 | 2017 | 194 | 0.15 | Why? |
| Survival Analysis | 5 | 2021 | 7592 | 0.15 | Why? |
| Light | 1 | 2017 | 306 | 0.15 | Why? |
| Severity of Illness Index | 5 | 2018 | 48226 | 0.15 | Why? |
| Male | 27 | 2021 | 367725 | 0.14 | Why? |
| Prevalence | 6 | 2021 | 25773 | 0.14 | Why? |
| Pulmonary Aspergillosis | 1 | 2020 | 408 | 0.14 | Why? |
| Transportation of Patients | 1 | 2020 | 494 | 0.14 | Why? |
| Antibodies, Antiphospholipid | 1 | 2019 | 519 | 0.14 | Why? |
| Prospective Studies | 6 | 2019 | 43301 | 0.14 | Why? |
| Aged | 18 | 2021 | 215776 | 0.13 | Why? |
| Troponin | 1 | 2020 | 1058 | 0.13 | Why? |
| Hospitals, High-Volume | 1 | 2018 | 688 | 0.13 | Why? |
| Lipopolysaccharides | 1 | 2018 | 848 | 0.13 | Why? |
| Female | 26 | 2021 | 380317 | 0.13 | Why? |
| Family | 2 | 2017 | 2909 | 0.12 | Why? |
| Interleukin-1beta | 1 | 2018 | 992 | 0.12 | Why? |
| Antiphospholipid Syndrome | 1 | 2019 | 533 | 0.12 | Why? |
| Tracheotomy | 1 | 2018 | 427 | 0.12 | Why? |
| Continuous Positive Airway Pressure | 2 | 2020 | 1187 | 0.12 | Why? |
| Physician's Role | 1 | 2021 | 853 | 0.12 | Why? |
| Cerebrovascular Disorders | 1 | 2020 | 1040 | 0.12 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.11 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.11 | Why? |
| Interleukin-6 | 2 | 2020 | 7522 | 0.11 | Why? |
| Bronchoscopy | 1 | 2019 | 991 | 0.11 | Why? |
| Depression | 3 | 2021 | 14116 | 0.11 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.11 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.11 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.11 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.10 | Why? |
| Rats | 1 | 2018 | 2764 | 0.10 | Why? |
| Patient Positioning | 1 | 2021 | 1505 | 0.10 | Why? |
| Empathy | 1 | 2017 | 658 | 0.10 | Why? |
| Pulmonary Disease, Chronic Obstructive | 2 | 2017 | 3832 | 0.10 | Why? |
| Survival Rate | 3 | 2020 | 9206 | 0.10 | Why? |
| Anxiety | 3 | 2021 | 17311 | 0.10 | Why? |
| Prone Position | 1 | 2021 | 1861 | 0.10 | Why? |
| Hematologic Neoplasms | 2 | 2019 | 2105 | 0.09 | Why? |
| Hypoxia | 3 | 2019 | 3626 | 0.09 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.09 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.08 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Immunoglobulins, Intravenous | 1 | 2017 | 2705 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.07 | Why? |
| Attitude to Death | 2 | 2017 | 307 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.06 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.06 | Why? |
| Renal Dialysis | 1 | 2020 | 4358 | 0.06 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
| Brain | 1 | 2020 | 5133 | 0.06 | Why? |
| Length of Stay | 2 | 2018 | 11042 | 0.06 | Why? |
| Hemodynamics | 2 | 2021 | 1562 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Physicians | 1 | 2021 | 4214 | 0.06 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.05 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2017 | 2963 | 0.05 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.05 | Why? |
| Adult | 12 | 2021 | 244371 | 0.05 | Why? |
| Pulmonary Ventilation | 1 | 2020 | 152 | 0.05 | Why? |
| Immunocompetence | 1 | 2020 | 280 | 0.05 | Why? |
| Transplantation Immunology | 1 | 2018 | 99 | 0.05 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.05 | Why? |
| Retreatment | 1 | 2018 | 186 | 0.04 | Why? |
| Pulmonary Gas Exchange | 1 | 2020 | 414 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2021 | 893 | 0.04 | Why? |
| Qualitative Research | 2 | 2021 | 4337 | 0.04 | Why? |
| Equipment Failure | 1 | 2018 | 197 | 0.04 | Why? |
| Catheterization | 1 | 2019 | 264 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Respiratory Mechanics | 1 | 2020 | 585 | 0.04 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Masks | 1 | 2017 | 8528 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.04 | Why? |
| APACHE | 1 | 2017 | 682 | 0.03 | Why? |
| Mental Health | 1 | 2021 | 15770 | 0.03 | Why? |
| Hydrogen-Ion Concentration | 1 | 2018 | 993 | 0.03 | Why? |
| Hospital Mortality | 4 | 2019 | 22087 | 0.03 | Why? |
| Oximetry | 1 | 2019 | 658 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Logistic Models | 2 | 2019 | 9089 | 0.03 | Why? |
| Airway Extubation | 1 | 2018 | 403 | 0.03 | Why? |
| Standard of Care | 1 | 2020 | 1297 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2019 | 865 | 0.03 | Why? |
| Nose | 1 | 2019 | 1093 | 0.03 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.03 | Why? |
| Fluid Therapy | 1 | 2017 | 628 | 0.03 | Why? |
| Belgium | 1 | 2018 | 2064 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.02 | Why? |
| Animals | 1 | 2018 | 78931 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Pulmonary Alveoli | 1 | 2012 | 867 | 0.02 | Why? |
| Respiration | 1 | 2012 | 729 | 0.02 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.02 | Why? |
| Burnout, Professional | 1 | 2021 | 2489 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2018 | 2844 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.02 | Why? |
| Attitude to Health | 1 | 2017 | 2002 | 0.02 | Why? |
| Organ Transplantation | 1 | 2018 | 2616 | 0.02 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.02 | Why? |
| Social Support | 1 | 2017 | 3183 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.01 | Why? |
| Communication | 1 | 2018 | 5206 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Adaptation, Psychological | 1 | 2017 | 4996 | 0.01 | Why? |
| Sleep | 1 | 2012 | 2695 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.01 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.01 | Why? |
| Thrombosis | 1 | 2019 | 7504 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.01 | Why? |
Demoule's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(199)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(164)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_